Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on September 17, 2026

Sep. 17, 2026

Becoming a Legal Nurse Consultant: What to Look for in a Program to Get the Best Results

Indeterminate EIN Presswire

Sep. 17, 2026

Healthcare AI Can Use Up to 4,600 Times More Energy Than Purpose-Built Systems, New Plainvue White Papers Report

Indeterminate EIN Presswire

Sep. 17, 2026

Skin Center of Florida Wins People's Choice Award in North Palm Beach

Indeterminate EIN Presswire

Sep. 17, 2026

US healthtech company Massive Bio expands Asia footprint with South Korea market push

Indeterminate EIN Presswire

Sep. 17, 2026

BioTech Social Announces Advisory Board to Advance Financial Innovation for Life Science Companies

Indeterminate GlobeNewswire

Sep. 17, 2026

Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D® Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure

Indeterminate GlobeNewswire

Sep. 17, 2026

Onco360® Has Been Selected as a National Pharmacy Partner for ETCAMAH™ (camizestrant)

Indeterminate GlobeNewswire

Sep. 17, 2026

NOMAD POWER SOLUTIONS FILES EXPANDED BUSINESS AND FINANCIAL DISCLOSURE FOLLOWING COMPLETION OF MERGER

Indeterminate GlobeNewswire

Sep. 17, 2026

Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3G or Primary IC-MPGN

Indeterminate GlobeNewswire

Sep. 17, 2026

Beta Bionics Announces Closing of $172.5 Million Public Offering of Common Stock

Indeterminate GlobeNewswire

Sep. 17, 2026

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 17, 2026

Vireo Growth Inc. Announces Issuance of Shares in Connection with Altmore Settlement

Indeterminate GlobeNewswire

Sep. 17, 2026

argenx announces results of Extraordinary General Meeting of Shareholders and appointment of Thomas M. Brakel and Khurem Farooq as Non-Executive Directors

Indeterminate GlobeNewswire

Sep. 17, 2026

Xenon Announces Azetukalner NDA Submission to FDA for Focal Seizures and Provides Update on Psychiatry Clinical Program

Indeterminate GlobeNewswire

Sep. 17, 2026

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 17, 2026

MAPS Attends Historic FDA Hearing on Psychedelics

Indeterminate GlobeNewswire

Sep. 17, 2026

Ultragenyx Announces Approval of FAYUVI™ Gene Therapy, the First-Ever FDA-Approved Treatment for Sanfilippo Syndrome Type A (MPS IIIA)

Indeterminate GlobeNewswire

Sep. 17, 2026

GOA Therapeutics Emerges from Stealth with $15.5 Million in Funding and Unveils GOA26, a First-in-Class Drug Candidate for Acute Alcohol Intoxication and Poisoning

Indeterminate GlobeNewswire

Sep. 17, 2026

AVAVA Announces $45 Million Financing Led by Catalio Capital Management to Accelerate Next Phase of Growth

Indeterminate GlobeNewswire

Sep. 17, 2026

FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A

Indeterminate GlobeNewswire